Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medicinova (MNOV) Interest & Investment Income (2021 - 2025)

Medicinova (MNOV) has disclosed Interest & Investment Income for 5 consecutive years, with $301876.0 as the latest value for Q4 2025.

  • On a quarterly basis, Interest & Investment Income changed N/A to $301876.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.5 million, a N/A change, with the full-year FY2025 number at $1.3 million, down 21.97% from a year prior.
  • Interest & Investment Income was $301876.0 for Q4 2025 at Medicinova, down from $336111.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $1.5 million in Q4 2023 to a low of $34338.0 in Q2 2021.
  • A 5-year average of $346940.7 and a median of $336111.0 in 2025 define the central range for Interest & Investment Income.
  • Peak YoY movement for Interest & Investment Income: soared 1263.31% in 2023, then fell 21.91% in 2024.
  • Medicinova's Interest & Investment Income stood at $36467.0 in 2021, then skyrocketed by 595.85% to $253755.0 in 2022, then surged by 472.32% to $1.5 million in 2023, then crashed by 69.16% to $447847.0 in 2024, then plummeted by 32.59% to $301876.0 in 2025.
  • Per Business Quant, the three most recent readings for MNOV's Interest & Investment Income are $301876.0 (Q4 2025), $336111.0 (Q1 2025), and $447847.0 (Q3 2024).